Xencor, Inc. (XNCR): $31.26

-0.53 (-1.67%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add XNCR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 498

in industry

Xencor Inc (XNCR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering XNCR.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
12 $63 $34 $54 $32.43 66.51%

The Trend in the Analyst Price Target


Over the past 14 months, XNCR's average price target has gone up $10.55.

XNCR reports an average of 25.53% for its upside potential over the past 14 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 12 63 34 54.00 33.11 63.09%
2021-07-10 12 63 34 54.00 34.10 58.36%
2021-07-03 12 63 34 54.00 35.38 52.63%
2021-06-21 12 63 34 54.00 37.20 45.16%
2021-06-13 12 63 34 54.00 37.29 44.81%
2021-06-05 12 63 34 54.00 36.45 48.15%
2021-05-22 12 63 34 54.00 40.15 34.5%
2021-05-15 12 63 34 54.00 40.54 33.2%
2021-05-08 12 63 34 54.33 39.61 37.16%
2021-04-25 12 63 34 54.75 43.58 25.63%
2021-04-17 12 63 34 54.75 42.26 29.56%
2021-04-09 12 60 34 54.50 40.47 34.67%
2021-03-23 12 60 34 54.33 43.06 26.17%
2021-03-20 12 60 34 54.33 46.22 17.55%
2021-03-13 12 60 34 54.33 47.03 15.52%
2021-03-06 12 60 34 54.33 44.90 21%
2021-02-27 12 60 34 54.33 49.27 10.27%
2021-02-20 11 60 31 51.00 50.99 0.02%
2021-02-01 11 60 31 51.00 46.01 10.85%
2021-01-30 11 60 31 51.00 45.75 11.48%
2021-01-23 11 60 31 51.00 48.50 5.15%
2021-01-16 11 60 31 50.55 48.46 4.31%
2021-01-09 11 60 31 50.55 49.38 2.37%
2021-01-02 11 60 31 49.64 43.63 13.77%
2020-12-26 11 60 31 49.64 46.08 7.73%
2020-12-19 11 60 31 49.64 44.83 10.73%
2020-12-09 11 60 31 49.64 41.97 18.27%
2020-11-26 11 60 31 49.64 40.97 21.16%
2020-11-13 10 60 31 49.00 40.72 20.33%
2020-11-13 11 60 31 49.64 40.72 21.91%
2020-10-19 11 56 28 45.45 40.08 13.4%
2020-10-02 10 56 28 45.00 36.63 22.85%
2020-09-04 10 56 28 44.70 33.62 32.96%
2020-08-05 10 56 28 45.00 30.82 46.01%
2020-07-22 10 56 28 45.70 34.39 32.89%
2020-07-13 10 56 28 45.70 NA NA%
2020-05-31 11 56 21 43.45 NA NA%

XNCR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.41 4 6 0 0 0 11

The Trend in the Broker Recommendations


Over the past 35 weeks, XNCR's average broker recommendation rating worsened by 0.32.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for XNCR as an investment opportunity.

  • Xencor Inc's number of analysts covering the stock is greater than 90.01% of Pharmaceutical Products stocks.
  • The upside potential (average analyst target price relative to current price) of XNCR is greater than 89.86% of stocks in the mid market cap category.
  • The average analyst price target of XNCR is greater than 80.74% of Pharmaceutical Products stocks.
  • Xencor Inc's variance in analysts' estimates is less than 20.66% of all US stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Xencor Inc are REPL, RVNC and KRYS.

What is the outlook for XNCR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7003 seconds.